Semax 10mg Research Peptide

Semax 10mg is a synthetic heptapeptide research compound derived from a modified fragment of adrenocorticotropic hormone (ACTH). It consists of the ACTH (4–7) sequence with the addition of a Proline–Glycine–Proline extension at the C-terminus, a modification studied for its effects on molecular stability and central nervous system permeability in experimental models. Semax 10mg is supplied as a lyophilized powder with a reported purity greater than 99% and is intended exclusively for laboratory research use.

What Is Semax 10mg?

Semax 10mg is an experimental peptide originally developed in Russia for research involving neurological signaling, cognitive processes, and neuroprotective mechanisms. In laboratory and animal studies, Semax has been examined for its interaction with neurotransmitter systems, neuronal survival pathways, and stress-response signaling. Semax 10mg remains an experimental research compound and is not approved for human or animal use.

Research Background

Research into Semax has focused on its role as a modified ACTH fragment designed to enhance central nervous system exposure compared to unmodified peptides. Studies have explored its involvement in cognitive signaling pathways, ischemic injury models, and neuronal plasticity research.

The Pro–Gly–Pro extension is of particular research interest due to its proposed influence on blood–brain barrier permeability and peptide stability. All findings remain preclinical and have not been validated through large-scale human clinical trials.

Mechanisms of Research Interest

Enkephalin Regulation

Semax 10mg has been studied for its potential influence on enkephalin metabolism through inhibition of enkephalin-degrading enzymes, a mechanism examined in stress-response and nociception research models.

Neurotransmitter Modulation

Experimental findings suggest Semax may influence serotonergic signaling pathways, including changes in 5-hydroxyindoleacetic acid levels, and may sensitize dopaminergic systems without directly altering dopamine concentrations.

Neuroprotection Research

Laboratory studies have examined whether Semax may reduce oxidative stress markers and support neuronal survival and plasticity under experimentally induced stress conditions.

Cognitive Function Research

Semax 10mg has been investigated in research models assessing memory formation, learning processes, and recovery signaling following neurological injury.

All mechanisms described are experimental observations only and do not imply clinical or therapeutic benefit.

Molecular and Chemical Information

• Product Name: Semax 10mg

• Form: Lyophilized powder

• Purity: Greater than 99%

• Molecular Formula: C37H51N9O10S

• Molecular Weight: 831.9 g/mol

• Alternate Names: ACTH (4–7)PGP

Research Applications

Semax 10mg may be utilized by qualified researchers in laboratory investigations involving:

• Neurotransmitter signaling studies

• Cognitive pathway research

• Neuroprotection and oxidative stress models

• Central nervous system peptide research

All use must remain within controlled laboratory environments.

Regulatory Status and Use Disclaimer

• For research use only

• Not approved by the Food and Drug Administration

• Not intended for human or veterinary use

• Not intended to diagnose, treat, cure, or prevent any disease

• No established clinical safety, dosing, or efficacy data